Clinical Trial Update: Pertubation With Lignocaine in Endometriosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of lignocaine perturbation in endometriosis has completed, with assessment also addressing dysmenorrhea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea
• Endometriosis

Drugs mentioned

• Lignocaine (lidocaine)

Snippet

Sponsor: Isifer AB | Conditions: Endometriosis, Dysmenorrhea | Phase 2 | Status: COMPLETED